These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 7585012)

  • 21. Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470.
    Kido A; Tsujiuchi T; Morishita T; Tsutsumi M; Takahama M; Miyauchi Y; Mii Y; Tamai S; Konishi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1074-81. PubMed ID: 9849588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice.
    Huang ZH; Fan YF; Xia H; Feng HM; Tang FX
    World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.
    Schoof DD; Obando JA; Cusack JC; Goedegebuure PS; Brem H; Eberlein TJ
    Int J Cancer; 1993 Oct; 55(4):630-5. PubMed ID: 7691763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
    Konno H; Tanaka T; Matsuda I; Kanai T; Maruo Y; Nishino N; Nakamura S; Baba S
    Int J Cancer; 1995 Apr; 61(2):268-71. PubMed ID: 7535757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice.
    Hanahan D; Bergers G; Bergsland E
    J Clin Invest; 2000 Apr; 105(8):1045-7. PubMed ID: 10772648
    [No Abstract]   [Full Text] [Related]  

  • 26. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
    Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
    J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
    Parangi S; O'Reilly M; Christofori G; Holmgren L; Grosfeld J; Folkman J; Hanahan D
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2002-7. PubMed ID: 8700875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The host support niche as a control point for tumor dormancy: implications for tumor development and beyond.
    Hahnfeldt P
    Adv Exp Med Biol; 2013; 734():19-35. PubMed ID: 23143973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
    J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
    Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
    Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma.
    Holmgren L; Jackson G; Arbiser J
    Oncogene; 1998 Aug; 17(7):819-24. PubMed ID: 9779998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
    Shishido T; Yasoshima T; Denno R; Sato N; Hirata K
    Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.
    Oikawa T; Murakami K; Sano M; Shibata J; Wierzba K; Yamada Y
    Jpn J Cancer Res; 2001 Nov; 92(11):1225-34. PubMed ID: 11714448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
    Qian CN; Min HQ; Lin HL; Hong MH; Ye YL
    J Laryngol Otol; 1998 Sep; 112(9):849-53. PubMed ID: 9876375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of angiogenesis inhibitor TNP-470 against postoperative lung metastasis following removal of orthotopic transplanted human colon cancer: an experimental study.
    Oda H; Ogata Y; Shirouzu K
    Kurume Med J; 2001; 48(4):285-93. PubMed ID: 11830929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis research yields new approaches to cancer treatment and prognosis.
    Larsen NS
    J Natl Cancer Inst; 1993 Oct; 85(20):1629-30. PubMed ID: 7692073
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11.
    Maier JA; Delia D; Thorpe PE; Gasparini G
    Anticancer Drugs; 1997 Mar; 8(3):238-44. PubMed ID: 9095328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin.
    Day CP; Carter J; Bonomi C; Hollingshead M; Merlino G
    Int J Cancer; 2012 Jan; 130(1):190-9. PubMed ID: 21312195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.